Author:
Wei Guangchao,Jiang Ping,Li Chunxiao,Wei Shuhua,Jiang Yuliang,Sun Haitao,Wang Junjie
Publisher
Springer Science and Business Media LLC
Subject
Radiology, Nuclear Medicine and imaging
Reference42 articles.
1. Cooperberg MR, Lubeck DP, Mehta SS, Carroll PR. Time trends in clinical risk stratification for prostate cancer: implications for outcomes (data from CaPSURE). J Urol. 2003;170(6):S21–7.
2. Sylvester JE, Grimm PD, Blasko JC, Millar J, Skoglund S, Galbreath RW, et al. 15 year biochemical relapse free survival in clinical Stage T1 T3 prostate cancer following combined external beam radiotherapy and brachytherapy Seattle experience. Int J Radiat Oncol Biol Phys. 2007. https://doi.org/10.1016/j.ijrobp.2006.07.1382.
3. Potters L, Morgenstern C, Calugaru E, Fearn P, Jassal A, Presser J, et al. 12 year outcomes following permanent prostate brachytherapy in patients with clinically localized prostate cancer. J Urol. 2008;179(5):S20–4.
4. Stock RG, Cahlon O, Cesaretti JA, Kollmeier MA, Stone NN. Combined modality treatment in the management of high-risk prostate cancer. Int J Radiat Oncol Biol Phys. 2004;59(5):1352–9.
5. Stock RG, Cesaretti JA, Stone NN. Disease-specific survival following the brachytherapy management of prostate cancer. Int J Radiat Oncol Biol Phys. 2005;64(3):810–6.
Cited by
4 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献